(Hypertension. 1996;27:90-95.)
© 1996 American Heart Association, Inc.
Articles |
From the Third Department of Internal Medicine (S.T., K.F., N.K., Y.K.), University of the Ryukyus School of Medicine, Okinawa; the First Department of Internal Medicine (T.E.), Miyazaki Medical College, Miyazaki; the Second Department of Internal Medicine (Y.T.), Faculty of Medicine, Kyushu University, Fukuoka; the Research Laboratory (T.T.), Yoshitomi Pharmaceutical Industries, Ltd, Fukuoka; Seiwa Experimental Animals, Ltd (K.O.), Fukuoka; and the National Cardiovascular Center (S.T.), Osaka, Japan.
Correspondence to Shuichi Takishita, MD, Division of Hypertension and Nephrology, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565, Japan.
| Abstract |
|---|
|
|
|---|
Key Words: aldosterone catecholamines diuretics rats, inbred SHR renin-angiotensin system sodium, dietary
| Introduction |
|---|
|
|
|---|
In the present study, we used a 22 µmol/g sodium diet, the lowest amount consistent with normal growth.20 We aimed to investigate whether or not perinatal exposure to and subsequent placement on a 22 µmol/g sodium diet could affect the development and maintenance of hypertension and mechanisms regulating BP in SHR (F-1 generation). We also examined effects of a diuretic treatment started in breeders (F-0 generation) and continued in the F-1.
| Methods |
|---|
|
|
|---|
Experiment 1
Rats (n=16 of each dietary group) in both
F-0 and F-1 were used
for the study. At 6, 8, 12, and 20 weeks of age (both groups) plus 30
weeks (F-0 only), each rat was separately housed in a
metabolic cage for 24 hours to examine food and water
consumption and to collect urine. On the second day after return to
their own cages, BW, SBP, and HR were measured. BP and HR were measured
by tail plethysmography after preheating at 38 to 39°C for 10 minutes
(PE-300, Narco Biosystems). Urinary excretion of sodium and potassium
was estimated by using flame-photometry and creatinine
by Jaffé reaction. AER was measured by
radioimmunoassay.22
Experiment 2
Blood sampling for determination of serum
concentrations of
electrolytes, total protein, creatinine, and urea nitrogen
was performed in 12 rats of all groups at 8, 12, and 20 weeks and 30
weeks (F-0 only) of age. Arterial blood was drawn from the
abdominal aorta under ether anesthesia. Thereafter, the
heart and kidneys were removed, cleaned, and weighed. Measurements of
HW and KW in F-0 were performed only in rats at 30 weeks of age. Serum
items were measured by the automatic analyzer (Hitachi
712).
In another set of 12 rats of each dietary group, plasma catecholamine and renin concentrations were determined at 8, 12, and 20 weeks of age. At least 4 hours after recovery from ether anesthesia, 1.5 mL of arterial blood was obtained through the catheter inserted into the common carotid artery of the rat in a conscious and unrestrained state. Blood was collected in ice-cold tubes that contained EGTA and reduced glutathione for plasma catecholamine determination or EGTA-2Na for PRC assay. Plasma catecholamine was assayed for free NE and E separately by a radioenzymatic method.23 The sensitivity was 2 pg for both NE and E in a plasma sample of 50 µL. The intra-assay CV was 8.0% and 10.4%, respectively, and the interassay CV was 9.9% and 11.6%, respectively. PRC was measured by a radioimmunoassay method.24 The intra-assay CV was 4.9% and interassay CV was 7.5%.
Experiment 3
BP responses to IV administration of NE and
hexamethonium were examined in 10 rats of each group of
F-1 at 8, 12, and 20 weeks of age. Under ether anesthesia,
rats received PE-10 catheters connected to PE-50 polyethylene tubing
(Clay Adams) inserted into the abdominal aorta via the femoral artery
for measurement of arterial BP and into the
inferior vena cava via the femoral vein for administration
of drugs. The catheters were filled with heparinized 5% dextrose
solution and were exteriorized by passing them subcutaneously through
the dorsal skin of the neck and fixing them to the skin. The
arterial line was connected to a pressure transducer (P50,
Gould) for continuous recording of MAP and HR triggered by
pulsatile pressure on a chart recorder (RM-6200, Nihon Koden). At
least 4 hours after the rats recovered from the anesthesia,
resting MAP and HR were recorded in a conscious and unrestrained
state. After baseline measurements, pressor responses to NE and
depressor responses to hexamethonium were monitored. NE
bitartrate was injected at doses of 0.3, 1.0, and 3.0 µg/kg BW.
Thereafter, 3.0 mg/kg hexamethonium bromide was
administered. The drugs were dissolved in 5% dextrose solution.
Each chemical assay was made in samples at the same points of age in the three dietary groups together in one assay procedure.
Statistical Analysis
All values were expressed as
mean±SEM. Statistical
analysis was performed by using one-way ANOVA and the
Bonferroni method25 to evaluate the difference of each
item between G1 and G2 or G3 at the corresponding age in each
generation. In the cases of BW, SBP, HR, urinary excretions of
electrolytes, and creatinine, repeated-measures ANOVA
was also used. A value of P<.05 was considered
statistically significant.
| Results |
|---|
|
|
|---|
|
SBP and HR
In F-0, SBP became >170 mm Hg in all groups by
8 weeks of age
(Fig 1
). There was no significant difference in SBP between G1
and G2
throughout the observation period. Although SBP in G3 was not
significantly different from that in G1 up to 20 weeks of age, it was
lower than that at 30 weeks (P<.01). Average SBP at 30
weeks of age for G1, G2, and G3 was 192±3, 192±5, and
174±3 mm Hg,
respectively. In F-1, SBP became >160 mm Hg in all three groups by 8
weeks of age. The BP in G2 was higher than that in G1 at 8 weeks of age
(P<.05); thereafter, there was no difference between the
two groups. BP was significantly lower in G3 than in G1 at 12 and 20
weeks of age (P<.01). Average SBP at 20 weeks of age for
G1, G2, and G3 was 197±3, 200±3, and 177±2 mm Hg,
respectively.
HR decreased in association with an increase in SBP at 8 weeks of age in all the groups of both F-0 and F-1 and was restored gradually to the level measured at 6 weeks of age. There was no significant difference in HR among the groups (F=1.03 in F-0, 2.50 in F-2). The average HR at 20 weeks of age in F-1 for G1, G2, and G3 was 453±6, 458±7, and 468±4 beats per minute, respectively (F=1.88).
Urinary Excretion of Sodium, Potassium, and
Aldosterone
Twenty-fourhour excretion of urinary sodium and
potassium and the sodium-creatinine ratio are shown in
Table 1
. Sodium excretion was markedly less in G2 than
in G1 and was slightly larger in G3 compared with that in G1 in both
F-0 and F-1. A consistent difference in potassium excretion was
not found among the three groups. While creatinine
excretion was less in G3 (F=2.55 in F-0, 12.51 in F-1), the
creatinine coefficient (mg/100 g BW per 24 hours) showed no
difference among the groups in both F-0 and F-1 (data not shown).
Urinary sodium per creatinine (µmol/mg
creatinine per 24 hours) was higher in G3 at all ages
examined except 8 weeks in F-0 and higher at 12 and 20 weeks in F-1
compared with that in G1 (Table 1
).
|
AER is shown in Fig
1
(bottom). It was highest in G2 among the three
groups in both F-0 and F-1 except at 12 weeks of age in F-0, when there
was no difference between G2 and G3. AER in G3 was higher than that in
G1 at all points of age examined.
Serum Concentrations of Protein, Electrolytes,
Creatinine, and Urea Nitrogen
There was no difference in serum total
protein among the three
groups in either F-0 or F-1. Serum concentrations of potassium and
chloride were significantly lower in G3 than in G1 at all ages examined
in both F-0 and F-1 (P<.01), whereas no difference was
found in serum sodium concentration between the two groups. There was
no difference in serum electrolytes between G1 and G2 in either F-0 or
F-1. Creatinine concentrations were similar among the three
groups in both F-0 and F-1. Blood urea nitrogen in G3, however, was
elevated throughout the observation periods in the two generations. The
values in F-1 at 20 weeks of age are shown in Table 2
.
At 8 and 12 weeks of age, similar results were obtained (data not
shown).
|
Plasma Concentrations of Catecholamine and
Renin
Neither plasma NE nor E was significantly different among the
three groups at any age examined in F-0 and F-1. PRCs are shown in Fig
2
. In F-0, PRC at 8 weeks of age was
higher in G2 than in G1 (P<.01), whereas no significant
difference was found at 12 and 20 weeks of age between the two groups.
PRC in G3 was higher than that at corresponding ages in G1 and in G2
except at 8 weeks, when it did not differ from that in G2. In F-1, PRCs
in G1 and G2 were similar at all ages examined, whereas PRCs were
extremely higher in G3 compared with those in G1 and G2
(P<.01).
|
BP Response to NE and Hexamethonium
In baseline measurements
there was no significant difference in
MAP between G1 and G2 at 8, 12, and 20 weeks of age in F-1. MAP in the
mefruside group (G3) tended to be lower than that in G1. The average
values of MAP at 20 weeks of age for G1, G2, and G3 were 155±10,
158±7, and 135±5 mm Hg, respectively. The pressor response to NE
was
substantially the same among the three groups at 8, 12, and 20 weeks of
age, and reflex bradycardia was also similar (data not shown).
Depressor response to hexamethonium at a fixed dose of
3.0 mg/kg was not different among the three groups at 8, 12, and 20
weeks of age in both absolute and percentage expression. At 20 weeks of
age depressor response in G1, G2, and G3 was -23.5±2.6%,
-22.4±2.9%, and -25.4±2.4%, respectively
(F=0.342).
Weights of Hearts and Kidneys
HW/BW and KW/BW are shown in
Table 3
. Neither HW
nor the ratio of HW to BW was different between G1 and G2 at any age
examined in the two generations. On the other hand, these were
significantly smaller in G3 than those in G1 at 30 weeks of age in F-0
and at 12 and 20 weeks of age in F-1 (P<.01). KW-BW ratio
was smaller in G2 than in G1 in F-1, whereas it was larger in G3 than
in G1 at 30 weeks of age in F-0 and at 8 and 12 weeks of age in
F-1.
|
| Discussion |
|---|
|
|
|---|
Perinatal exposure to a sodium-deficient diet (17 µmol/g)15 or high sodium diet (1.3 mmol/g)8 has been shown to suppress or increase the adult BP of SHR or borderline hypertensive rats, respectively. Furthermore, the effects of perinatal and adult exposure to high dietary sodium were additive.8 In the present study, however, exposure to the low sodium diet from conception to adulthood could not suppress the BP measured at 6, 8, 12, and 20 weeks of age in F-1 SHR.
It has been accepted that the sympathetic nervous system is hyperactive and essential to the development of hypertension in SHR.26 27 Therefore, the failure to blunt the development of hypertension in the present study might be attributed to the absence of suppression of the sympathetic function. We assessed the sympathetic activity by measuring (1) plasma catecholamine, (2) extent of BP decrease in response to hexamethonium, and (3) BP responsiveness to an IV injection of NE. The findings that there were no differences in the three items tested between the control and low sodium groups in F-0 and F-1 are consistent with results from other studies. Winternitz and Oparil17 reported that a dietary sodium restriction (22 µmol/g) for 3 weeks from 7 weeks of age had no influence on either plasma catecholamine levels or the depressor response to hexamethonium. Toal and Leenen14 also found no remarkable changes in sympathetic function in SHR on a 26 µmol/g sodium diet from birth to 16 weeks of age. More severe restriction or depletion of sodium, however, was reported to decrease the sympathetic nervous function.2 28 In dogs on sodium depletion induced by a low sodium diet and a diuretic, the pressor response to carotid occlusion was blunted29 and renal sympathetic nerve activities were suppressed by less of an increase in arterial pressure compared with a normal sodium group.30 In SHR, Toal and Leenen14 demonstrated that a sodium-deficient diet (9 or 17 µmol sodium/g food) started at birth prevented or blunted the development of hypertension with depressed body growth. Although plasma catecholamine levels were higher, the BP-lowering effect of ganglion blockade was significantly less compared with that in SHR on the control diet (101 µmol/g).14 They concluded that a decreased pressor effect of the sympathetic nervous system in SHR on a sodium-deficient diet contributed to the blunted development of hypertension. Folkow and colleagues2 13 also reported that 5 µmol/g sodium diet suppressed BP and the peripheral sympathetic function and altered central catecholamine metabolism in SHR.
Therefore, it appears that the low sodium diet with minimal content of sodium for normal growth cannot suppress the sympathetic nervous function and the development of hypertension in SHR even in the present experimental conditions. We have reported31 32 that the same regimen of sodium as the current study suppressed the sympathetic function (lower plasma NE concentration and blunted depressor response to hexamethonium) and MAP in Wistar rats of the third generation (F-2) bred successively on the low sodium diet. A suppression of SBP measured by tail plethysmography and the tendency of a suppression of depressor response to ganglion blockade were found even in F-1.32 The inconsistency between SHR and Wistar normotensive rats might be due to the differences in basal activity of the sympathetic nervous system, strain, and/or the length of sodium restriction over the generations.
Dietary sodium restriction also has been known to enhance the renin-angiotensin-aldosterone system. It is possible that the hypotensive effects of the low sodium diet are offset by compensatory increased renin-angiotensin system. In the present study, however, PRC in the low sodium group was not elevated in F-0 and F-1 except at 8 weeks of age in F-0 compared with that in the control group. High PRC at 8 weeks of age in F-0 may be considered to be a short-term response to sodium restriction because the rats had been on the low sodium diet for only 3 weeks. Moderate sodium restriction with 26 µmol/g sodium from birth was also reported not to cause significant increases in plasma renin activity or the BP response to captopril at 16 weeks of age in SHR.33 The findings may be consistent with those of Morotomi et al,34 who noted that renal renin content was increased in both Wistar rats and SHR fed the low sodium food for 7 days but not in these rats on the food from weaning for 9 weeks. Normal PRC was also found in our previous study on Wistar rats bred on the low sodium diet, which was confirmed further by the pressure response to an infusion of saralasin, an angiotensin II analogue, that was similar to that in the control sodium group.32 Taken together, these results suggest that a readjustment of renin synthesis and release in the kidney may occur in rats on long-term dietary restriction of sodium. Severe sodium restriction, however, elicited a marked increase in plasma renin activity, an increased depressor response to captopril, and a marked decrease in pressor response to angiotensin II.33
In contrast to the findings of PRC in the present study, urinary AER increased in the low sodium group more than that in the diuretic group, where PRC was elevated. The dissociation between PRC and AER was also found in the aforementioned three generations (F-0, F-1, and F-2) of Wistar rats on the low sodium diet.31 32 Therefore, it may be reasonable to consider that the regulatory mechanisms of the renin-angiotensin system and aldosterone metabolism are not always in the same direction under long-term moderate sodium restriction but that aldosterone may play a more important role than angiotensin II in maintaining sodium homeostasis, at least in rats in this situation.
The diuretic treatment with mefruside21 decreased the adult BP, which was associated with the growth inhibition in both F-0 and F-1 SHR maintained on the control sodium diet. Suppressed BP was confirmed by the reduced HW-BW ratio. Although the sympathetic function was not influenced by long-term treatment, PRC was elevated at any age in both F-0 and F-1. Elevated PRC levels are consistent with the report that diuretic treatment causes an increase in granularity of juxtaglomerular cells in rats.35 While creatinine excretion was less in the diuretic group compared with that in the other two groups, the creatinine coefficient (mg/g BW per 24 hours) showed no difference among the three groups. Urinary sodium excretion and the excretion per creatinine were larger in the diuretic group compared with those in the control sodium group in both F-0 and F-1. Lower concentrations of serum chloride and potassium and higher urea nitrogen level were also reflections of diuretic effects of mefruside. These findings may explain the suppressed BP and high levels of PRC. Although the causes of reduced BW were not clear, it could not be attributed solely to a reduction in body fluid. Less urinary excretion of creatinine may indicate smaller muscle mass, which partly explains the reduced BW in the diuretic group. The KW-BW ratio was larger in the diuretic group than in the control group. We did not perform a pathological study of the kidney and have no explanation for the finding.
In summary, dietary sodium restriction with the least sodium for normal growth failed to blunt the development of hypertension in SHR placed on the diet from conception to adulthood, which was in contrast to the diuretic treatment. An enhanced urinary AER without an increase in PRC was demonstrated in association with normal sympathetic nervous function. The results in the present experimental conditions suggest that aldosterone played an important role in maintaining sodium homeostasis, which did not blunt the development of hypertension in conjunction with preserved sympathetic function.
| Selected Abbreviations and Acronyms |
|---|
|
| Footnotes |
|---|
Received April 18, 1995; first decision May 31, 1995; accepted September 6, 1995.
| References |
|---|
|
|
|---|
2. Folkow B, Ely DL. Dietary sodium effects on cardiovascular and sympathetic neuroeffector functions as studied in various rat models. J Hypertens. 1987;5:383-395. [Medline] [Order article via Infotrieve]
3. Harrap SB, Doyle AE. Total body sodium in immature spontaneously hypertensive and Wistar Kyoto rats. Clin Exp Pharmacol Physiol. 1985;12:315-318. [Medline] [Order article via Infotrieve]
4. Vanderwalle A, Farman N, Bonvalet JP. Renal handling of sodium in Kyoto-Okamoto rats: a micropuncture study. Am J Physiol. 1978;235:F394-F402.
5.
Beierwaltes WH, Arendshorst WJ, Klemmer PJ.
Electrolyte and water balance in young spontaneously
hypertensive rats. Hypertension. 1982;4:908-915.
6. Karr-Dullien V, Bloomquist E. The influence of prenatal salt on the development of hypertension by spontaneously hypertensive rats (SHR). Proc Soc Exp Biol Med. 1979;160:421-425. [Medline] [Order article via Infotrieve]
7. Azar S, Kabat V, Bingham C. Environmental factor(s) during suckling exert long-term effects upon blood pressure and body weight in spontaneously hypertensive and normotensive rats. J Hypertens. 1991;9:309-327. [Medline] [Order article via Infotrieve]
8.
Hunt RA, Tucker DC. Developmental sensitivity
to high dietary sodium chloride in borderline hypertensive
rats. Hypertension. 1993;22:542-550.
9. Grollman A, Grollman EF. The teratogenic induction of hypertension. J Clin Invest. 1962;41:710-714.
10.
Contreras RJ. Differences in perinatal NaCl
exposure alters blood pressure levels of adult rats. Am J
Physiol. 1989;256:R70-R77.
11. Louis WJ, Tabei R, Spector S. Effect of sodium intake on inherited hypertension in the rat. Lancet. 1971;2:1283-1286. [Medline] [Order article via Infotrieve]
12. Toal CB, Leenen FHH. Dietary sodium restriction and development of hypertension in spontaneously hypertensive rats. Am J Physiol. 1983;245:H1081-H1084.
13. Ely DL, Folkow B, Paradise NF. Risks associated with dietary sodium reduction in the spontaneous hypertensive rat model of hypertension. Am J Hypertens. 1990;3:650-660. [Medline] [Order article via Infotrieve]
14. Toal CB, Leenen FHH. Dietary sodium restriction, blood pressure and sympathetic activity in spontaneously hypertensive rats. J Hypertens. 1987;5:107-113. [Medline] [Order article via Infotrieve]
15.
Di Nicolantonio R, Hoy K, Spargo S, Morgan TO.
Perinatal salt intake alters blood pressure and salt balance in
hypertensive rats. Hypertension. 1990;15:177-182.
16. Wright GL, McMurtry JP, Wexler BC. Food restriction reduces the blood pressure of the spontaneously hypertensive rat. Life Sci. 1981;28:1253-1259. [Medline] [Order article via Infotrieve]
17. Winternitz SR, Oparil S. Sodium-neural interactions in the development of spontaneous hypertension. Clin Exp Hypertens. 1982;A4:751-760.
18. Wilczynski EA, Leenen FHH. Dietary sodium intake and age in spontaneously hypertensive rats: effects on blood pressure and sympathetic activity. Life Sci. 1987;41:707-715. [Medline] [Order article via Infotrieve]
19.
Zicha J, Kunes J, Lelinek J. Experimental
hypertension in young and adult animals.
Hypertension. 1986;8:1096-1104.
20. Grunert RR, Meyer JH, Phillips PH. The sodium and potassium requirements of the rat for growth. J Nutr. 1950;32:609-618.
21. Brogden RN, Speight TM, Avery GS. Mefruside: a preliminary report of its pharmacological properties and therapeutic efficacy in oedema and hypertension. Drugs. 1974;7:419-425. [Medline] [Order article via Infotrieve]
22. Kawasaki T, Nakamuta S, Muratani H, Omae T. A simple radioimmunoassay determination of urinary aldosterone using 125I-labelled ligand (ALDOCTK-125KIT) and its clinical application. Folia Endocrinol Jpn. 1984;60:696-705.
23. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay for norepinephrine, epinephrine and dopamine. Life Sci. 1977;21:625-636. [Medline] [Order article via Infotrieve]
24. Shibota M, Nagaoka A, Shino A, Fujita T. Renin-angiotensin system in stroke-prone spontaneously hypertensive rats. Am J Physiol. 1979;236:H409-H416.
25.
Wallenstein S, Zucker CL, Fleiss JL. Some
statistical methods useful in circulation research.
Circ Res. 1980;47:1-9.
26. Judy WV, Watanabe AM, Henry DP, Besch HR, Murphy WR, Hockel GM. Sympathetic nerve activity: role in regulation of blood pressure in the spontaneously hypertensive rat. Circ Res. 1976;38(suppl II):II-21-II-29.
27. Provoost AP, de Jong W. Differential development of renal, DOCA-salt, and spontaneous hypertension in the rat after neonatal sympathectomy. Clin Exp Hypertens. 1979;1:177-189.
28. Vollmer RR. Effects of dietary sodium on sympathetic nervous system control of cardiovascular function. J Auton Pharmacol. 1984;4:133-144. [Medline] [Order article via Infotrieve]
29. Szilagyi JE, Masaki Z, Brosnihan KB, Ferrario CM. Neurogenic suppression of carotid sinus reflexes by vagal afferents in sodium-depleted dogs. Am J Physiol. 1981;241:H255-H262.
30. Takishita S, Ferrario CM. Altered neural control of cardiovascular function in sodium-depleted dogs. Hypertension. 1982;4(suppl II):II-175-II-182.
31. Takishita S, Fukiyama K, Kawazoe N, Eto T, Takata Y, Kimura Y, Tomita Y, Fujishima M. Suppressed sympathetic function without enhanced renin-angiotensin system in rats bred successively on low-sodium diet. J Hypertens. 1986;4(suppl 3):S463-S464.
32. Kawazoe N, Takishita S, Eto T, Fukiyama K, Takata Y, Abe I, Kimura Y, Tomita Y, Tsuchihashi T, Fujishima M. Arterial pressure and its regulation in rats bred successively on low sodium diet. Fukuoka Acta Med. 1993;84:127-137.
33. Leenen FHH, Toal CB. Dietary sodium restriction and the renin-angiotensin system in young spontaneously hypertensive rats. J Hypertens. 1989;7:57-61. [Medline] [Order article via Infotrieve]
34. Morotomi Y, Tanaka K, Omae T. Effects of sodium intake and angiotensin administration on renal renin content and blood pressure in spontaneously hypertensive rats. Jpn Heart J. 1973;14:165-167.
35. Tobian L, Janecek J, Foker J, Ferreisa D. Effects of chlorothiazide on renal juxtaglomerular cells and tissue electrolytes. Am J Physiol. 1962;202:905-908.
This article has been cited by other articles:
![]() |
J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |